This is a question that some Senators and the American people should consider, especially since health care reform legislation is being debated in the U.S. Senate. Recently, we are fortunate to be in a country that has led with medical advancements, whether it is utilizing adult stem cells to find cures for diseases, such as cancer and diabetes, or experimental drugs that give hope to those with terminal illnesses. Could this be compromised with ObamaCare?
One can see from the recent reviews by the U.S. Preventative Task Force that there will be some rationing included in ObamaCare. The recent reviews regarding preventative measures for womens health definitely points to the fact that medical advancements might be impacted. The recent recommendations by this task force to push mammograms from age 40 to 50, and pap smears from age 18 to 21, are just a few examples of routine screenings that might be affected by ObamaCare. (Note: Thankfully, Kathleen Sebelius, Secretary of Health and Human Services, stepped in and said that these routine health care measures would continue to stay the same.)
However, as we can see in countries with universal health care/public options, medical innovations have been impacted. What new innovations have we seen from Canada or the U.K. recently? Hmmm…nothing.